Effects of variation in retinol binding protein 4 gene and adipose specific expression of gestational diabetes in Beijing, China

Diabetes Research and Clinical Practice

Volumn 97, Issue 2, 2012, Pages 283-289

  Ping, Fan ^a   Xiang, Hong Ding ^a   Li, Ming ^a   Li, Wei ^a   Liu, Jun Tao ^a   Nie, Min ^a   Hui, Yuan Chi ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Gestational diabetes mellitus; Retinol binding protein 4; Single nucleotide polymorphism

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MESSENGER RNA; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CELL FUNCTION; CHINA; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; GESTATIONAL IMPAIRED GLUCOSE TOLERANCE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEUKOCYTE; MAJOR CLINICAL STUDY; NORMAL GLUCOSE TOLERANCE; PANCREAS ISLET BETA CELL; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RETINOL BINDING PROTEIN 4 GENE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; ADULT; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHINA; DIABETES, GESTATIONAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSE INTOLERANCE; HAPLOTYPES; HUMANS; INFANT, NEWBORN; INSULIN RESISTANCE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; RETINOL-BINDING PROTEINS, PLASMA; RNA, MESSENGER;

EID: 84865095548     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.02.017     Document Type: Article

References (37)

1. Diagnosis and classification of diabetes mellitus. Diabetes Care (2007) 30 (Suppl. 1): S42-S47.
2. Berkowitz G.S., Lapinski R.H., Wein R., Lee D. Race/ethnicity and other risk factors for gestational diabetes. Am J Epidemiol 1992, 135:965-973.
3. Koukkou E., Taub N., Jackson P., Metcalfe G., Cameron M., Lowy C. Difference in prevalence of gestational diabetes and perinatal outcome in an innercity multiethnic London population. Eur J Obstet Gynecol Reprod Biol 1995, 59:153-157.
4. Silva J.K., Kaholokula J.K., Ratner R., Mau M. Ethnic differences in perinatal outcome of gestational diabetes mellitus. Diabetes Care 2006, 29:2058-2063.
5. Yue D.K., Molyneaux L.M., Ross G.P., Constantino M.I., Child A.G., Turtle J.R. Why does ethnicity affect prevalence of gestational diabetes? The underwater volcano theory. Diabet Med 1996, 13:748-752.
6. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007, 30(Suppl. 2):S141-S146.
7. Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436:356-362.
8. Tamori Y., Sakaue H., Kasuga M. RBP4, an unexpected adipokine. Nat Med 2006, 12:30-31. [discussion 31].
9. Graham T.E., Yang Q., Bluher M., Hammarstedt A., Ciaraldi T.P., Henry R.R., et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006, 354:2552-2563.
10. Meigs J.B., Panhuysen C.I., Myers R.H., Wilson P.W., Cupples L.A. A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study. Diabetes 2002, 51:833-840.
11. Duggirala R., Blangero J., Almasy L., Dyer T.D., Williams K.L., Leach R.J., et al. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet 1999, 64:1127-1140.
12. Munkhtulga L., Nakayama K., Utsumi N., Yanagisawa Y., Gotoh T., Omi T., et al. Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia. Hum Genet 2007, 120:879-888.
13. Craig R.L., Chu W.S., Elbein S.C. Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits. Mol Genet Metab 2007, 90:338-344.
14. Kovacs P., Geyer M., Berndt J., Kloting N., Graham T.E., Bottcher Y., et al. Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression. Diabetes 2007, 56:3095-3100.
15. Hu C., Jia W., Zhang R., Wang C., Lu J., Wu H., et al. Effect of RBP4 gene variants on circulating RBP4 concentration and type 2 diabetes in a Chinese population. Diabet Med 2008, 25:11-18.
16. Li M., Wu C.Y., Song A.L., Zhang K. Development and preliminary application of enzyme-linked immunosorbent assay for human net insulin in serum. Chin J Endocrinol Metab 1997, 13:214-217.
17. Kirwan J.P., Huston-Presley L., Kalhan S.C., Catalano P.M. Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 2001, 24:1602-1607.
18. Hanson R.L., Pratley R.E., Bogardus C., Narayan K.M., Roumain J.M., Imperatore G., et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 2000, 151:190-198.
19. Bergman R.N., Ader M., Huecking K., Van Citters G. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 2002, 51(Suppl. 1):S212-S220.
20. Consolandi C. High-throughput multiplex HLA-typing by ligase detection reaction (LDR) and universal array (UA) approach. Methods Mol Biol 2009, 496:115-127.
21. Tian F., Wu Y., Zhou Y., Liu X., Visvikis-Siest S., Xia Y. A new single nucleotide polymorphism genotyping method based on gap ligase chain reaction and a microsphere detection assay. Clin Chem Lab Med 2008, 46:486-489.
22. Qin S., Zhao X., Pan Y., Liu J., Feng G., Fu J., et al. An association study of the N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray. Eur J Hum Genet 2005, 13:807-814.
23. Kuhl C. Etiology and pathogenesis of gestational diabetes. Diabetes Care 1998, 21(Suppl. 2):B19-B26.
24. Metzger B.E., Lowe L.P., Dyer A.R., Trimble E.R., Chaovarindr U., Coustan D.R., et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008, 358:1991-2002.
25. Landon M.B., Spong C.Y., Thom E., Carpenter M.W., Ramin S.M., Casey B., et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009, 361:1339-1348.
26. Metzger B.E., Gabbe S.G., Persson B., Buchanan T.A., Catalano P.A., Damm P., et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010, 33:676-682.
27. Di C.G., Volpe L., Lencioni C., et al. Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract 2003, 62:131-137.
28. Cho Y.M., Kim T.H., Lim S., Choi S.H., Shin H.D., Lee H.K., et al. Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia 2009, 52:253-261.
29. Freathy R.M., Hayes M.G., Urbanek M., Lowe L.P., Lee H., Ackerman C., et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: common genetic variants in GCK and TCF7L2 are associated with fasting and postchallenge glucose levels in pregnancy and with the new consensus definition of gestational diabetes mellitus from the International Association of Diabetes and Pregnancy Study Groups. Diabetes 2010, 59:2682-2689.
30. Nadal A., Alonso-Magdalena P., Soriano S., Ropero A.B., Quesada I. The role of oestrogens in the adaptation of islets to insulin resistance. J Physiol 2009, 587:5031-5037.
31. Butte N.F. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000, 71:S1256-S1261.
32. Kloting N., Graham T.E., Berndt J., et al. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 2007, 6:79-87.
33. Wu Y., Li H., Loos R.J., Qi Q., Hu F.B., Liu Y., et al. RBP4 variants are significantly associated with plasma RBP4 levels and hypertriglyceridemia risk in Chinese Hans. J Lipid Res 2009, 50:1479-1486.
34. Qi Q., Yu Z., Ye X., Zhao F., Huang P., Hu F.B., et al. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 2007, 92:4827-4834.
35. Xu M., Li X.Y., Wang J.G., Wang X.J., Huang Y., Cheng Q., et al. Retinol-binding protein 4 is associated with impaired glucose regulation and microalbuminuria in a Chinese population. Diabetologia 2009, 52:1511-1519.
36. Jia W., Wu H., Bao Y., Wang C., Lu J., Zhu J., et al. Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab 2007, 92:3224-3229.
37. Graham T.E., Wason C.J., Bluher M., Kahn B.B. Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia 2007, 50:814-823.